Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CANDESARTAN CILEXETIL
- Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
- Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
- Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin
- The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions
- Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
- Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
- An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
- Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
- DP-R208 Pharmacokinetic Study
- Clinical Trial to Compare the Pharmacokinetics of DP-R208
- Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects
- Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs
- Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy
- A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria
- Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
- Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」
- Bioequivalence Study of CJ-30059
- Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"
- A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323
- Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"
- A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension
- Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil
- Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)
- Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
- Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions
- Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects
- Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate
- Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension
- Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
- Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
- Recurrent Stroke Prevention Clinical Outcome Study
- The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
- Impact of Diabetes on Left Ventricular Remodeling
- Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension
- Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal
- Bioequivalence Study in Healthy Subjects
- Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure
- Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)
- Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24
- Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)
- Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)
- Blood Pressure Lowering in Acute Stroke Trial (BLAST)
- Candesartan Effect in Second Stage Arterial Hypertension
- Atacand (Candesartan) Real Life Study
- Angiotensin-II Blockade in Mitral Regurgitation
- Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
- ARIA (Atacand Renoprotection In NephropAthy Pt.)
- Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
- Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
- Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody
- Diabetic Retinopathy Candesartan Trials
- DIabetic Retinopathy Candesartan Trials.
- DIabetic Retinopathy Candesartan Trials
- Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age
- Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age
- Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age
- High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
- TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial
- Prophylactic Treatment of Episodic Cluster Headache
- Danish Hypertension Prevention Project - DHYPP
- Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
- Scandinavian Candesartan Acute Stroke Trial (SCAST)
- Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
Clinical trials list
click for details